General primary-care telehealth with GLP-1 prescribing — broad practice scope, less weight-management specialization
PlushCare is a general primary-care telehealth platform that offers GLP-1 prescribing as part of its broader practice. PlushCare's clinical bench is exclusively MD and DO (no NPs), which is a structural strength versus telehealth competitors who lean more heavily on NPs. The platform has a long operating history (since 2014) and is acquired by Accolade, providing operational stability.
For patients who already use PlushCare for primary care, adding GLP-1 prescribing into the same relationship is convenient. The visit-based pricing model is more transparent than program-fee structures — you pay $99 per visit, $17/month for membership, and medication separately through your insurance or cash-pay.
PlushCare is not a weight-management specialist platform — GLP-1 prescribing is one offering among many. Patients seeking the structured behavioral support, dose-titration coaching, and weight-management curriculum offered by Form, Sequence, or NexLife will find PlushCare's GLP-1 program comparatively bare. PlushCare focuses on brand-name FDA-approved medications and does not offer a compounded pathway, which makes it expensive for uninsured-and-uncovered patients. The visit-based pricing means follow-ups during titration are billable visits, not included in a flat fee.
PlushCare is the right pick for patients who already use it for primary care and want to add GLP-1 prescribing into the same relationship. As a standalone weight-management choice, NexLife and Form are stronger.
PlushCare pricing ranges from $16.99/mo + $99 visit. Starting price is $99/month. Pricing details and any titration upcharges are described above in the pricing section.
PlushCare is an established telehealth program. Good for patients with insurance who want traditional primary-care telehealth. Always verify a provider's pharmacy partnerships, prescribing physician credentials, and state availability before signing up.
Most direct-to-consumer compounded GLP-1 programs do not accept insurance for the medication itself. If insurance coverage matters to you, see our insurance pathway providers (Mochi Health, Ro, Form Health) and our insurance hub.
PlushCare prescribes: Wegovy, Zepbound, Ozempic (off-label).
PlushCare is available in All 50 states.
Eligibility is determined by an intake questionnaire and clinical review. Generally, FDA-approved weight-loss criteria are BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity (Type 2 diabetes, hypertension, dyslipidemia, sleep apnea). Off-label compounded prescribing is at the discretion of the prescribing clinician.
Editorial note. By GLP Agonists Editorial · Last updated May 2026. This review is editorially independent. See our methodology and editorial disclosure. Not medical advice — always consult a licensed clinician.